STAND. COM. REP. 1226
Honolulu, Hawaii
, 2003
RE: S.B. No. 1361
S.D. 2
H.D. 1
Honorable Calvin K.Y. Say
Speaker, House of Representatives
Twenty-Second State Legislature
Regular Session of 2003
State of Hawaii
Sir:
Your Committee on Consumer Protection and Commerce, to which was referred S.B. No. 1361, S.D. 2, H.D. 1, entitled:
"A BILL FOR AN ACT RELATING TO PRESCRIPTION DRUGS,"
begs leave to report as follows:
The purpose of this bill is to improve patient outcomes and reduce drug costs to consumers and third party insurers by:
The Hawaii Medical Service Association, Hawaii Pharmacists Association, The Chamber of Commerce of Hawaii, and Kaiser Permanente testified in support of this measure.
Your Committee finds that one of the drivers fueling the rising cost of health care is the increased demand for prescription drugs. Drug therapeutic equivalency evaluations of the Food and Drug Administration are available to pharmacists and other interested parties months before the same information is available through hardcopy publications. This measure will speed
up the process through which a generic drug becomes available to Hawaii's consumers and can offer dramatic cost savings to consumers and third party insurers.
As affirmed by the record of votes of the members of your Committee on Consumer Protection and Commerce that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 1361, S.D. 2, H.D. 1, and recommends that it pass Third Reading.
Respectfully submitted on behalf of the members of the Committee on Consumer Protection and Commerce,
____________________________ KENNETH T. HIRAKI, Chair |
||